Company Active LTD

Company profile

Bitfount Ltd

UK company 12390975, incorporated on 7 January 2020.

Federated Data Science and AI Platform | Bitfount

Bitfount is a complete federated data science and AI platform. Enterprise-grade, privacy-preserving, compliant data collaborations without any data sharing.

Company number
12390975
Incorporated
7 Jan 2020
Companies House status
Active

Company identity

Founded / incorporated
7 January 2020

Company number 12390975

Verify at Companies House
Legal name
BITFOUNT LTD
Company type
Private Limited Company
Region
London
Registered address
128 CITY ROAD
LONDON
ENGLAND
EC1V 2NX
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 1
1
Company Active LTD
Bitfount Ltd
CRN 12390975
2
Direct and ultimate controller Active LTD
Bluejay Holdings Ltd
CRN 12390968

Latest accounts

Financial period: 1 Feb 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
16

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

20 Jan
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

06 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

07 Jan
2020

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2022
Funded years
2022
Age at first award
2 years

Projects

2022 Collaborative R&D Lead participant

Demonstrating the efficacy at scale of a novel data-protecting AI system for surfacing clinically-eligible patients for clinical trials

1 Mar 2022 to 31 Aug 2023

Awarded
£256,418
Total cost £366,311

**Issue** **Clinical trial participant identification is desperately manual, time-consuming and frequently fails. As such, it is a well-known bottle-neck to healthcare R&D.** **Clinical recruitment is a two-fold process: patient identification, followed by screening**. In order to identify patients with specific clinical presentation and attributes, pharm...

Product types

Collaborative R&D